Reply

Affiliations

¹ Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: maguirem@mail.med.upenn.edu.
² Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.

Comment

Maureen G Maguire et al. Ophthalmology. 2017 Mar.

. 2017 Mar;124(3):e33.

doi: 10.1016/j.ophtha.2016.06.046.

¹ Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: maguirem@mail.med.upenn.edu.
² Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania.

No abstract available

Comment on

Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group; Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, et al. Ophthalmology. 2016 Aug;123(8):1751-1761. doi: 10.1016/j.ophtha.2016.03.045. Epub 2016 May 2. Ophthalmology. 2016. PMID: 27156698 Free PMC article. Clinical Trial.
Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761).
Gillies MC, Daien V, Nguyen V, Barthelmes D. Gillies MC, et al. Ophthalmology. 2017 Mar;124(3):e31-e32. doi: 10.1016/j.ophtha.2016.05.054. Ophthalmology. 2017. PMID: 28219517 No abstract available.